{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T01:09:28Z","timestamp":1778375368133,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,9]]},"DOI":"10.7759\/cureus.108568","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:58:36Z","timestamp":1778374716000},"source":"Crossref","is-referenced-by-count":0,"title":["Post-prostate Biopsy Septic Shock Due to Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli: A Case Report"],"prefix":"10.7759","author":[{"given":"Joseph","family":"Trainer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Khosid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268815002885","article-title":"The global burden of major infectious complications following prostate biopsy","volume":"144","author":"Bennett HY","year":"2016","unstructured":"Bennett HY, Roberts MJ, Doi SA, Gardiner RA. The global burden of major infectious complications following prostate biopsy. Epidemiol Infect. 2016, 144:1784-91. 10.1017\/S0950268815002885","journal-title":"Epidemiol Infect"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14824","article-title":"Post-prostate biopsy acute bacterial prostatitis and screening cultures using selective media: An overview","volume":"29","author":"Acosta H","year":"2022","unstructured":"Acosta H, Sadahira T, Sekito T, et al.. Post-prostate biopsy acute bacterial prostatitis and screening cultures using selective media: An overview. Int J Urol. 2022, 29:486-93. 10.1111\/iju.14824","journal-title":"Int J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum \u03b2-lactamase-producing Escherichia coli infection in the United States","volume":"56","author":"Doi Y","year":"2013","unstructured":"Doi Y, Park YS, Rivera JI, et al.. Community-associated extended-spectrum \u03b2-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013, 56:641-8. 10.1093\/cid\/cis942","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac268","article-title":"Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum \u03b2-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa)","volume":"75","author":"Tamma PD","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum \u03b2-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis. 2022, 75:187-212. 10.1093\/cid\/ciac268","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2043-8","article-title":"Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature","volume":"22","author":"Ehrman RR","year":"2018","unstructured":"Ehrman RR, Sullivan AN, Favot MJ, Sherwin RL, Reynolds CA, Abidov A, Levy PD. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature. Crit Care. 2018, 22:112. 10.1186\/s13054-018-2043-8","journal-title":"Crit Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005930","article-title":"Role of admission troponin-T and serial troponin-T testing in predicting outcomes in severe sepsis and septic shock","volume":"6","author":"Vallabhajosyula S","year":"2017","unstructured":"Vallabhajosyula S, Sakhuja A, Geske JB, et al.. Role of admission troponin-T and serial troponin-T testing in predicting outcomes in severe sepsis and septic shock. J Am Heart Assoc. 2017, 6:10.1161\/JAHA.117.005930","journal-title":"J Am Heart Assoc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130158","article-title":"The acute respiratory distress syndrome: pathogenesis and treatment","volume":"6","author":"Matthay MA","year":"2011","unstructured":"Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011, 6:147-63. 10.1146\/annurev-pathol-011110-130158","journal-title":"Annu Rev Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06326-x","article-title":"Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study","volume":"21","author":"MacKinnon MC","year":"2021","unstructured":"MacKinnon MC, McEwen SA, Pearl DL, et al.. Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study. BMC Infect Dis. 2021, 21:606. 10.1186\/s12879-021-06326-x","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.33393\/dti.2022.2422","article-title":"The association of ESBL Escherichia coli with mortality in patients with Escherichia coli bacteremia at the emergency department","volume":"16","author":"Phungoen P","year":"2022","unstructured":"Phungoen P, Sarunyaparit J, Apiratwarakul K, Wonglakorn L, Meesing A, Sawanyawisuth K. The association of ESBL Escherichia coli with mortality in patients with Escherichia coli bacteremia at the emergency department. Drug Target Insights. 2022, 16:12-6. 10.33393\/dti.2022.2422","journal-title":"Drug Target Insights"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans L","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021, 47:1181-247. 10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040635","article-title":"Early use of low-dose hydrocortisone can reduce in-hospital mortality in patients with septic shock: a systematic review and meta-analysis","volume":"103","author":"Song B","year":"2024","unstructured":"Song B, Zheng X, Fu K, Liu C. Early use of low-dose hydrocortisone can reduce in-hospital mortality in patients with septic shock: a systematic review and meta-analysis. Medicine (Baltimore). 2024, 103:e40635. 10.1097\/MD.0000000000040635","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50814","article-title":"Early versus late initiation of hydrocortisone in patients with septic shock: a prospective study","volume":"15","author":"Alsulami M Sr","year":"2023","unstructured":"Alsulami M Sr, Alrojaie L, Omaer A. Early versus late initiation of hydrocortisone in patients with septic shock: a prospective study. Cureus. 2023, 15:e50814. 10.7759\/cureus.50814","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/470640-post-prostate-biopsy-septic-shock-due-to-extended-spectrum-beta-lactamase-esbl-producing-escherichia-coli-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:58:37Z","timestamp":1778374717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/470640-post-prostate-biopsy-septic-shock-due-to-extended-spectrum-beta-lactamase-esbl-producing-escherichia-coli-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.108568","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,9]]}}}